Polysialylated NCAM (PSA-NCAM), a key glycoprotein in neural plasticity, is generally reduced in patients with AD, particularly in the entorhinal cortex and hippocampus62 (Fig. 2). Here, NCAM1 is linked to Alzheimer disease.